{{vm.title}}
25{{vm.includesText}}
{{item}}
{{vm.selectText}}
{{ vm.welcomeLabel.trim() }},
{{ vm.userName }}
{{ vm.text }}
{{vm.newUser1}} {{vm.newUser2}} {{vm.newUser3}} {{vm.newUser4}}
{{ vm.unknownUser }}
{{ vm.title }}
{{ vm.title }}
{{ vm.title }}
- {{ vm.siteSelectorList.flyout.cell1.heading }} {{ site.countryLocale }} {{ vm.siteSelectorList.flyout.cell1.global.countryLocale }}
{{ vm.closeTabLabel }}
- {{ vm.flyout.cell2.title }} {{ vm.flyout.cell2.newTabAllow }} {{ vm.flyout.cell2.title }}
- {{ vm.flyout.cell3.title }} {{ vm.flyout.cell3.newTabAllow }} {{ vm.flyout.cell3.title }}
- {{ vm.flyout.cell1.viewAll.label }} {{ vm.flyout.cell1.viewAll.newTabAllow }} {{ vm.flyout.cell1.viewAll.label }}
Nutraceuticals: The future of intelligent food
Nutraceuticals: The future of intelligent food
The nutraceuticals market is predicted to be worth $250 billion by 2018; how can food and pharma companies act now to secure a slice of success?
Highlights
- Download Nutraceuticals: The future of intelligent food report
The global nutraceuticals market is predicted to be worth $250 billion by 2018 as a result of increased uptake by health savvy consumers. Our report, Nutraceuticals: The future of intelligent food, delves into some of the challenges and opportunities facing both food and pharmaceutical companies. It also explores the six main areas companies must excel in if they want to succeed in this growing market.
Key insights:
- Nutraceuticals are set to play a central role in preventative healthcare with manufacturers becoming part of patient care pathways
- Future superfoods could potentially tackle the underlying causes of conditions, such as diabetes, obesity and cardiovascular disease, by linking diet to the human genome
- Food companies have a greater understanding of nutrition, food formulation and decades of consumer research to support growth in this area, but lack the scientific resources to achieve game-changing breakthroughs
- The pharmaceutical industry has strong research capabilities and stakeholder relationships, however the typical organisational structure may struggle to adapt to the fast pace of the Nutraceuticals market - and have limited knowledge of the consumer compared to food companies
- Successful companies will have to hit the bulls-eye in six main areas: technology, product strategy, compliance, marketing, supply chain management and corporate deal making
Would you like to receive updates about new publications and events directly to your email?
© 2019 KPMG LLP, a UK limited liability partnership, and a member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative, a Swiss entity. All rights reserved.
KPMG International Cooperative (“KPMG International”) is a Swiss entity. Member firms of the KPMG network of independent firms are affiliated with KPMG International. KPMG International provides no client services. No member firm has any authority to obligate or bind KPMG International or any other member firm vis-à-vis third parties, nor does KPMG International have any such authority to obligate or bind any member firm.
This article represents the views of the author only, and does not necessarily represent the views or professional advice of KPMG in the UK.
